Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update

被引：0

作者：

Voorhees, Peter M. ^{[1
]}

Kaufman, Jonathan L. ^{[2
]}

Laubach, Jacob P. ^{[3
]}

Sborov, Douglas W. ^{[4
]}

Reeves, Brandi ^{[5
]}

Rodriguez, Cesar ^{[6
]}

Chari, Ajai ^{[7
]}

Silbermann, Rebecca W. ^{[8
]}

Costa, Luciano J. ^{[9
]}

Anderson, Larry D. ^{[10
]}

Nathwani, Nitya ^{[11
]}

Shah, Nina D. ^{[12
]}

Efebera, Yvonne A. ^{[13
]}

Costello, Caitlin L. ^{[14
]}

Jakubowiak, Andrzej ^{[15
]}

Wildes, Tanya M. ^{[16
]}

Orlowski, Robert Z. ^{[17
]}

Shain, Kenneth H. ^{[18
]}

Cowan, Andrew J. ^{[19
]}

Murphy, Sean ^{[20
]}

Lutska, Yana ^{[20
]}

Pei, Huiling ^{[21
]}

Ukropec, Jon ^{[22
]}

Vermeulen, Jessica ^{[23
]}

de Boer, Carla ^{[23
]}

Hoehn, Daniela ^{[20
]}

Lin, Thomas S. ^{[20
]}

Richardson, Paul G. ^{[3
]}

机构：

[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA

[5] Univ N Carolina, Chapel Hill, NC 27515 USA

[6] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA

[7] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA

[8] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[9] Univ Alabama Birmingham, Birmingham, AL USA

[10] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX USA

[11] City Hope Comprehens Canc Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Duarte, CA USA

[12] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[13] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[14] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[15] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[16] Washington Univ, Div Oncol, Sect Med Oncol, St Louis, MO USA

[17] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[18] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, St Petersburg, FL USA

[19] Univ Washington, Div Med Oncol, Seattle, WA USA

[20] Janssen Sci Affairs LLC, Horsham, PA USA

[21] Janssen Res & Dev LLC, Titusville, NJ USA

[22] Janssen Global Med Affairs, Horsham, PA USA

[23] Janssen Res & Dev LLC, Leiden, Netherlands

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

691

引用

页数：7

共 50 条

[1] Depth of Response to Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone Improves Over Time in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma: Griffin Study Update
Voorhees, Peter M.
Kaufman, Jonathan L.
Laubach, Jacob
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Murphy, Sean
Lutska, Yana
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
De Boer, Carla
Hoehn, Daniela
Lin, Thomas S.
Richardson, Paul G.
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 127 - 128
[2] Daratumumab (DARA) plus Lenalidomide/Bortezomib/Dexamethasone (RVd) in African American/Black Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of GRIFFIN
Nooka, Ajay K.
Kaufman, Jonathan L.
Rodriguez, Cesar
Jakubowiak, Andrzej
Shune, Leyla
Badros, Ashraf
Chari, Ajai
Richardson, Paul G.
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
Hoehn, Daniela
Lin, Thomas S.
Voorhees, Peter M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S308 - S309
[3] Daratumumab (DARA) plus lenalidomide/bortezomib/dexamethasone (RVd) in Black patients with transplant-eligible newly diagnosed multiple myeloma (NDMM): an updated subgroup analysis of GRIFFIN
Nooka, Ajay
Kaufman, Jonathan
Rodriguez, Cesar
Jakubowiak, Andrzej
Efebera, Yvonne
Reeves, Brandi
Wildes, Tanya
Holstein, Sarah
Anderson, Larry
Badros, Ashraf
Shune, Leyla
Chari, Ajai
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Lin, Thomas
Usmani, Saad
Richardson, Paul
Voorhees, Peter
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S155 - S156
[4] Daratumumab plus Lenalidomide, Bortezomib & Dexamethasone Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN
Voorhees, Peter
Kaufman, Jonathan L.
Laubach, Jacob
Sborov, Douglas
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca
Costa, Luciano
Anderson, Larry
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew
Murphy, Sean
Lutska, Yana
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
de Boer, Carla
Hoehn, Daniela
Lin, Thomas
Richardson, Paul G.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E353 - E354
[5] Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 24 Months of Maintenance
Kaufman, Jonathan L.
Laubach, Jacob P.
Sborov, Douglas
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca W.
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Holstein, Sara A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Lutska, Yana
Bobba, Padma
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
Lin, Thomas S.
Richardson, Paul G.
Voorhees, Peter M.
BLOOD, 2021, 138
[6] Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): A Subgroup Analysis of Griffin
Anderson, Larry D., Jr.
Kaufman, Jonathan L.
Laubach, Jacob P.
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca W.
Costa, Luciano J.
Nathwani, Nitya
Shah, Nina
Bumma, Naresh
Holstein, Sarah A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Voorhees, Peter M.
Richardson, Paul G.
BLOOD, 2021, 138
[7] Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN Primary Analysis
Chari, Ajai
Voorhees, Peter M.
Kaufman, Jonathan L.
Laubach, Jacob
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Silbermann, Rebecca
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Ander J.
Murphy, Sean
Lutska, Yana
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
de Boer, Carla
Hoehn, Daniela
Lin, Thomas S.
Richardson, Paul G.
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S31 - S31
[8] Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy
Kaufman, Jonathan L.
Laubach, Jacob P.
Sborov, Douglas
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca W.
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Holstein, Sara A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Lutska, Yana
Bobba, Padma
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
Lin, Thomas S.
Richardson, Paul G.
Voorhees, Peter M.
BLOOD, 2020, 136
[9] Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Voorhees, Peter M.
Kaufman, Jonathan L.
Laubach, Jacob
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Holstein, Sarah A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Murphy, Sean
Lutska, Yana
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
de Boer, Carla
Hoehn, Daniela
Lin, Thomas S.
Richardson, Paul G.
BLOOD, 2020, 136 (08) : 936 - 945
[10] Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Efficacy and Safety Analysis of the Safety Run-in Population of Griffin
Voorhees, Peter M.
Rodriguez, Cesar
Reeves, Brandi
Nathwani, Nitya
Costa, Luciano J.
Lutska, Yana
Bobba, Padma
Hoehn, Daniela
Pei, Huiling
Ukropec, Jon
Qi, Ming
Lin, Thomas S.
Richardson, Paul G.
BLOOD, 2020, 136

← 1 2 3 4 5 →